Cut Putri Hazlianda
Universitas Sumatera Utara

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

Guttate Psoriasis that Evolves to Chronic Plaque Psoriasis induced by Atypical Bacterial Infection Jesryn Dhillon; Cut Putri Hazlianda
Indonesian Journal of Global Health Research Vol. 7 No. 6 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i6.168

Abstract

Guttate psoriasis is the second most common variant of psoriasis found in children and young adults. It is known that several factors such as infections, alcohol consumption, drugs, trauma, acute discontinuation of potent topical or systemic corticosteroids, body mass index, and endocrine disorders are known to be associated with the occurrence and development of guttate tu. This study aims to report a case of varicella with bronchopneumonia in an adult patient. Data were collected through anamnesis, physical examination, laboratory and microbiological investigations, and follow-up assessments, then analyzed qualitatively and presented descriptively as a case report. A 27-year-old man came to our polyclinic with multiple erythematous papules and multiple plaques, milliar-lenticular-nummular in size, discrete, accompanied by the white scale on the scalp, thoracic, vertebral, axillary, right, and left brachial and lower extremities. Two throat swab examinations showed different bacterias and were later found to be induced by periodontitis. This patient was then treated for chronic plaque psoriasis with methotrexate and showed good progress.
The Interplay Between Food Allergy and Atopic Dermatitis: Mechanism, Diagnosis, and Management Ike Martyani; Cut Putri Hazlianda
Indonesian Journal of Global Health Research Vol. 8 No. 3 (2026): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v8i3.1235

Abstract

Atopic dermatitis (AD) and food allergy (FA) are two conditions that frequently coexist and present significant challenges in both diagnosis and management. This review aims to describe the link between atopic dermatitis and food allergy, as well as their diagnosis, management, and prevention, especially in the Asian context. The findings indicate that impairment of the skin barrier and exposure to food allergens through the skin (epicutaneous sensitization) play central roles in the development of FA among individuals with AD. From a diagnostic perspective, it is essential to distinguish between food sensitization and clinically significant food allergy in order to avoid unnecessary elimination diets. Management strategies encompass comprehensive care for AD, including skin-barrier maintenance and anti-inflammatory therapy, alongside evaluation for FA when clinically indicated, and avoidance of confirmed trigger foods. Preventive efforts, particularly in high-risk infants, show promise through early skin-barrier care and controlled introduction of food allergens. In the Indonesian and broader Asian contexts, adaptation of these strategies should consider local dietary patterns and the availability of allergy and dermatology services.
Update on Adult Dermatomyositis Cut Putri Hazlianda; Awalia Astarina
Indonesian Journal of Global Health Research Vol. 8 No. 3 (2026): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v8i3.1387

Abstract

Dermatomyositis is a systemic autoimmune disorder that is an inflammatory disease of the skin, muscles, and blood vessels with characteristic skin eruptions accompanied by proximal limb muscle weakness or atrophy. This condition can affect children and adults. The pathognomonic lesions are the heliotrope sign, Gottron's papule, and Gottron's sign Malignancy can occur in 10%- 20%, with nasopharyngeal cancer being the most common. Etiology and pathogenesis are autoimmune; other triggers include drugs, infection, sun exposure, and malignancy. The latest diagnosis criteria by EULAR/ACR 2017 and Sontheimer et al. can be used as a reference for diagnosis. Comprehensive management of dermatomyositis aims to decrease symptoms, increase quality of life, and early detection of malignancy. Topical therapy options for dermatomyositis are topical calcineurin inhibitors and corticosteroids. In addition, systemic therapy consists of steroid- sparing agents, antimalarials, and corticosteroids. The current treatment of dermatomyositis is the administration of intravenous Immunoglobulin (IVIG) and rituximab.